Sandra Helton Net Worth

The estimated Net Worth of Sandra L Helton is at least $4.59 Million dollars as of 19 October 2022. Ms. Helton owns over 1,000 units of Covetrus stock worth over $750,330 and over the last 21 years she sold CVET stock worth over $3,517,562. In addition, she makes $322,500 as Independent Director at Covetrus.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Helton CVET stock SEC Form 4 insiders trading

Sandra has made over 18 trades of the Covetrus stock since 2005, according to the Form 4 filled with the SEC. Most recently she sold 1,000 units of CVET stock worth $80,020 on 19 October 2022.

The largest trade she's ever made was selling 30,000 units of Covetrus stock on 13 May 2005 worth over $1,220,700. On average, Sandra trades about 753 units every 46 days since 2003. As of 19 October 2022 she still owns at least 35,747 units of Covetrus stock.

You can see the complete history of Ms. Helton stock trades at the bottom of the page.

Sandra Helton biography

Sandra L. Helton is Independent Director of the Company. Ms. Helton was Executive Vice President and Chief Financial Officer of Telephone and Data Systems, Inc. (“TDS”), a telecommunications organization that includes US Cellular Corporation, from 1998 through 2006. In her role, Ms. Helton had responsibility for finance, information technology and other corporate functions. She also served on the Board of Directors of TDS. She served as Vice President and Corporate Controller of Compaq Computer Corporation from 1997 through 1998. Previously, Ms. Helton spent over 20 years with Corning Incorporated, a technology company, where she held engineering, strategy and finance positions, including Senior Vice President and Treasurer from 1991 through 1997. Since 2001, Ms. Helton serves on the Board of Directors of Principal Financial Group, Inc., and is currently Chair of its audit committee and a member of its executive committee and finance committee. Since February 2018, she has been a Director of OptiNose, Inc., and is Chair of its audit committee. Ms. Helton previously served as a Director of Lexmark International, Inc., including as a member of its audit committee. Ms. Helton also previously served as a member of the Board of Directors of Covance, Inc. and as Chair of its audit and finance committee and a member of its nominating and governance committee. Ms. Helton is currently a trustee of two non-profit organizations, Northwestern Memorial Foundation (serving on its executive committee) and the Chicago Architectural Center (serving at various points in the past as Chair of its finance committee, Chair of its governance committee and member of its executive committee). Ms. Helton received a B.S. in mathematics from the University of Kentucky and a S.M. from the Massachusetts Institute of Technology’s Sloan School, with double majors in Finance and Planning & Control.

What is the salary of Sandra Helton?

As the Independent Director of Covetrus, the total compensation of Sandra Helton at Covetrus is $322,500. There are 8 executives at Covetrus getting paid more, with Benjamin Wolin having the highest compensation of $4,065,210.

How old is Sandra Helton?

Sandra Helton is 70, she's been the Independent Director of Covetrus since 2019. There are 1 older and 25 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.

What's Sandra Helton's mailing address?

Sandra's mailing address filed with the SEC is C/O OPTINOSE, INC., 777 TOWNSHIP LINE ROAD, SUITE 300, YARDLEY, PA, 19067.

Insiders trading at Covetrus

Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin, and Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.

What does Covetrus do?

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.

Complete history of Ms. Helton stock trades at Principal Inc, Telephone And Data Systems, OptiNose Inc, Principal Inc, and Covetrus

Covetrus executives and stock owners

Covetrus executives and other stock owners filed with the SEC include:

• Benjamin Wolin,
  President, Chief Executive Officer, Director
• Dustin Finer,
  Chief Administrative Officer
• Georgina Wraight,
  Executive Vice President, President - Global Technology Solutions
• Benjamin Wolin,
  CEO, Pres & Director
• Georgina Wraight,
  Exec. VP & Pres of Global Technology Solutions
• Matthew J. Foulston,
  Exec. VP & Global CFO
• Philip Laskawy,
  Independent Chairman of the Board
• Dustin k. Finer,
  Chief Admin. Officer
• Sandra Helton,
  Independent Director
• Ravi Sachdev,
  Independent Director
• Edward McNamara,
  Independent Director
• Mark Manoff,
  Independent Director
• Deborah Ellinger,
  Independent Director
• Steven Paladino,
  Director
• Nicholas Jansen,
  Vice President of Investor Relations
• Sandra Peterson,
  Director
• Arman Samani,
  Chief Product Officer
• Steve Palmucci,
  Global Chief Information Officer
• Laura Phillips,
  Chief Accounting Officer, Vice President, Global Controller
• Erin Brennan,
  Senior Vice President, General Counsel, Secretary
• Anthony Providenti,
  Executive Vice President, Corporate Development
• Timothy Ludlow,
  Executive Vice President, Chief Transformation Officer
• David Hinton,
  Executive Vice President, President - APAC and Emerging Marke
• Michael Ellis,
  Executive Vice President, President - Europe and North America
• Matthew Malenfant,
  President, Customer Operations - North America
• Matthew Foulston,
  Global Chief Financial Officer
• Russell Cooke,
  Sr. VP & Operational CFO
• Ditte Marstrand Wulf,
  Global Chief HR Officer
• Kini Schoop,
  Director of PR
• Andrew B. Coxhead,
  VP, Corp. Controller & Chief Accounting Officer
• Bekki Kidd,
  Head of Operations & Operational Excellence
• Kiní Schoop,
  Director of PR
• Jamey S. Seely,
  Gen. Counsel & Corp. Sec.
• Paul R. Fonteyne,
  Director
• Andrew B. Coxhead,
  See Remarks
• Benjamin Shaw,
  Chief Executive Officer
• Investment Associates Ix, L...,
  
• Christine T Komola,
  See Remarks
• Sharon L Wienbar,
  Director
• Jamey S Seely,
  General Counsel and Secretary
• David Christopher Dollar,
  See Remarks
• Rebecca Ann Kidd,
  Head of Global Operations